Affini-T Therapeutics
PrivateLast Round
VC Round
Oct 15, 2024
Total Funding Raised
$175M
Company Overview
Affini-T is a biotechnology company focused on developing precision immunotherapies that target key oncogenic driver mutations to create potentially curative treatments for patients with solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Affini-T Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Affini-T Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 15, 2024 | ||||
| Series A | Mar 22, 2022 |
Affini-T Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series A |
| Vida Ventures | Series A |
| Parker Institute for Cancer Immunotherapy | Series A |
| Catalio Capital Management | Series A |
| Humboldt Fund | Series A |
| Leaps by Bayer | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2025
Will present at the 43rd Annual J.P. Morgan Healthcare Conference.
Affini-T Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Affini-T Therapeutics's valuation, stock price, and market status.
